Forschungsartikel
TP53 is a Mutational Target in Non Small Cell Lung Cancer Patients and its Pro/Pro Variant is Potentially Contributing to Cancer Susceptibility
-
Saxena Alpana, Javid J, Mir R, Masroor M, Ahamad I, Farooq S, Yadav P, Zuberi M, Ajaz Ah Bhat, Ahmad I, Khalanin T, Julka PK, Mohan A, Lone M, Banday MA and Ray PC